Latest Type 1 hypersensitivity Stories
Phase 1b Data Presented at Late Breaking Session of 71st Annual Meeting of the American Academy of Dermatology PARIS and TARRYTOWN, N.Y., March 2, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that pooled data from two Phase 1b trials with dupilumab (REGN668/SAR231893), an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting the alpha subunit of the interleukin 4...
Lawrence LeBlond for redOrbit.com - Your Universe Online Though not the most common occurrence, researchers do sometimes discover drugs marketed for one particular disease, disorder or illness can work well in treating a totally different condition. One recent discovery was that of a popular diabetes drug that showed promise in treating ovarian cancer. Another--not so recent--discovery was of the antidepressant drug Wellbutrin that proved to be effective in helping smokers kick the habit....
redOrbit Staff & Wire Reports - Your Universe Online Two pharmaceutical companies have issued a recall of their anemia drug Omontys after receiving reports that some kidney dialysis patients had suffered severe allergic reactions after taking the medication. According to the Associated Press (AP), California-based Affymax Inc. and Illinois-based Takeda Pharmaceutical Co. said some of the more than 25,000 patients who had received the drug had experienced adverse effects afterwards,...
Beat Eczema is the newly updated treatment for eczema created by Susan Clark, who claims to show sufferers how to cure eczema in less than ten days. A full Beat Eczema review in a series of health reviews shows if the method is natural and safe for people to use. Seattle, WA (PRWEB) February 22, 2013 Beat Eczema is the latest treatment developed by Susan Clark, who claims to show people the treatment for eczema naturally and safely. The treatment method will show users how to get rid of...
BASKING RIDGE, N.J., Feb. 20, 2013 /PRNewswire/ -- Since Mylan Specialty L.P., the fully-integrated specialty pharmaceutical business of Mylan Inc. (Nasdaq: MYL), launched the EpiPen4Schools(TM) program in August 2012, thousands of schools across the country have elected to participate and redeem free EpiPen(®) or EpiPen Jr(®) (epinephrine) Auto-Injectors. The program was created to help schools have improved access to epinephrine in the event a person experiences a...
BASKING RIDGE, N.J., Jan. 31, 2013 /PRNewswire/ -- Valentine's Day brings the exchange of cards and candy, and marks a popular time for social events and dates involving food. But for parents whose children have life-threatening food allergies, it is also a time for continuing their important dialogue about avoiding allergic triggers and preparedness should anaphylaxis (a life-threatening allergic reaction) occur. This importance is highlighted by a recent survey* revealing that as...
BRIDGEWATER, N.J., Jan. 29, 2013 /PRNewswire/ -- Jerome Bettis and Robin Miller are teaming up with Sanofi US to raise awareness of life-threatening allergic reactions (anaphylaxis) and spread the word that Auvi-Q(TM) (epinephrine injection, USP) is now available by prescription in pharmacies nationwide. Bettis, who is allergic to shellfish, and Miller, who is allergic to eggs, hope to help educate adults and caregivers of children at risk for severe allergic reactions. To view the...
BRIDGEWATER, N.J., Jan. 28, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that Auvi-Q(TM) (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider. (Photo: http://photos.prnewswire.com/prnh/20130128/NY48939 ) Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions in people who are at risk...
MONTREAL, Jan. 25, 2013 /CNW/ - Sanofi Canada announces a new option for the emergency treatment of anaphylaxis. Allerject(TM) is the first and only 'talking' epinephrine auto-injector in Canada. "Sanofi is excited about being able to offer Allerject(TM)," says Jon Fairest, President and CEO of Sanofi Canada. "Allerject(TM) is designed to address unmet patient needs and make a positive difference in the lives of those at risk of a severe allergic reaction, and those who care for...
HayMax, a revolutionary and specially formulated organic allergy relief balm, is now available on Amazon.com, the leader in ecommerce. Boca Raton, Florida (PRWEB) January 14, 2013 HayMax, a revolutionary and specially formulated organic allergy relief balm, is now available on Amazon.com, the leader in ecommerce. Created by an entrepreneur who suffered for years with hay fever, HayMax prevents allergens from entering the nasal cavity before they can cause allergic reactions. This results...
